Some people find they owe money back for subsidies if their income changed from what they estimated. In 2026, more people may find themselves in this situation — and face higher repayment amounts — if they don’t carefully track their income.
Despite public opposition to the cuts they made to federal health programs in 2025, Republicans reportedly are considering more cuts to help pay for the war in Iran. Meanwhile, the Supreme Court ruled that Colorado cannot ban “conversion therapy” for LGBTQ+ minors. Jessie Hellmann of CQ Roll Call, Alice Miranda Ollstein of Politico, and Sandhya Raman of Bloomberg Law join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Elisabeth Rosenthal, who wrote the last two “Bill of the Month” stories.
This week, the CDC began to publish long-awaited data that will reveal the extent of measles’ comeback. While applauding the science, researchers say the Trump administration has done little to contain the virus. “That we’re even talking about this is nuts,” one virologist said.
North Carolina rolled out a $3.1 billion insurance plan for kids in foster care, but many doctors did not accept patients on the plan. The state is one of several experimenting with a model that has left kids’ guardians scrambling to find health care providers.
After Eric Tennant died, his widow vowed to speak out against West Virginia’s Public Employees Insurance Agency, which had denied cancer treatment recommended by Tennant’s doctor. Her efforts paid off. In March, West Virginia’s governor signed a bill to protect some patients from harm tied to prior authorization.
About 17,000 federally funded health clinics stand to collectively lose $32 billion under GOP-backed fiscal policies in the next five years — just as more uninsured patients will rely on them for low-cost care.
Behind their warm-and-fuzzy marketing, infant formula industry giants Abbott, maker of Similac products, and Mead Johnson, maker of the Enfamil line, have turned neonatal intensive care units into arenas of brutal competition.
A sweeping set of regulations issued in February includes Trump administration proposals to curb what Obamacare critics contend are fraud incentives.
The Trump administration faces the challenge of naming a new director of the Centers for Disease Control and Prevention who can both satisfy the Make America Healthy Again movement and get confirmed by the Senate. Meanwhile, a new Senate bill to rescind the approval of the abortion pill mifepristone is again elevating the abortion debate, which some Republicans would prefer to stay on the back burner until after the midterms. Shefali Luthra of The 19th, Lizzy Lawrence of Stat, and Rachel Cohrs Zhang of Bloomberg News join KFF Health News’ Julie Rovner to discuss the news. Also this week, Rovner interviews Georgetown University Law Center’s Katie Keith about the state of the Affordable Care Act on its 16th anniversary.
Two Americans explain how the skyrocketing cost of health insurance influenced their decision to buy — or skip — health insurance in 2026.
